Clinical Trial Update: Best Noninvasive Predictor of Renal Function in Assessing Adult Sickle Nephropathy

View source ↗

Summary

The clinical trial evaluating a noninvasive predictor of renal function in adults with sickle nephropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Sickle Cell Disease | Status: COMPLETED